Sildenafil Tablet, Film Coated
Product Images NDC 72303-0847

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 72303-0847). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hec Pharm Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Logo0001-01 (Logo0001 01)

FDA Label Image

Logo0001-02 (Logo0001 02)

FDA Label Image

Logo0001-03 (Logo0001 03)

FDA Label Image

Logo0001-04 (Logo0001 04)

FDA Label Image

Fugure1 (Sildenafil Fig1)

A line graph showing the mean change from baseline in sitting systolic blood pressure over 24 hours post-dose for healthy volunteers. Two groups are compared: Sildenafil 100 mg and placebo. The y-axis measures systolic blood pressure change in mmHg, and the x-axis represents time in hours post-dose, starting from pre-dose to 24 hours.*

FDA Label Image

Figure10 (Sildenafil Fig10)

Label for Sildenafil Tablets, USP 50 mg film-coated oral tablets by HEC Pharm USA Inc. The label indicates a package containing 100 tablets for prescription use only. It includes storage instructions, manufacturer information, and an NDC number 48792-7912-2.*

FDA Label Image

Sildenafil-fig11 (Sildenafil Fig11)

Label for Sildenafil tablets USP by HEC Pharm USA Inc., film-coated oral tablets containing 100 mg sildenafil citrate per tablet. The package contains 30 tablets and is marked Rx only. Storage and distribution details are included, along with a barcode and revision date.*

FDA Label Image

Figure12 (Sildenafil Fig12)

Sildenafil Tablets, USP 100 mg film-coated tablets label showing NDC 48792-7913-2. The label indicates the product is manufactured for HEC Pharm USA Inc. and prepared by Sunshine Lake Pharma Co., Ltd. It includes storage instructions and states the package contains 100 tablets for prescription use only.*

FDA Label Image

Fugure2 (Sildenafil Fig2)

A line graph illustrating mean standing systolic blood pressure change from baseline over 8 hours postdose. It compares changes between two groups: one receiving Doxazosin plus placebo, and the other receiving Doxazosin plus 25 mg Sildenafil. The y-axis represents change in systolic blood pressure in mmHg, and the x-axis is time in hours after dosing.*

FDA Label Image

Figure3 (Sildenafil Fig3)

A line graph showing the mean standing systolic blood pressure change from baseline over an 8-hour period postdose. Two series are compared: Doxazosin + Placebo and Doxazosin + Sildenafil 50 mg. The y-axis represents change in SBP (mmHg), and the x-axis represents time postdose (hours). The graph includes a legend for the two treatment groups.*

FDA Label Image

Figure4 (Sildenafil Fig4)

A line graph showing mean standing systolic blood pressure change from baseline over 8 hours after dosing. Two data series are shown: one for Doxazosin combined with Sildenafil 100 mg and another for Doxazosin combined with Placebo. The y-axis measures blood pressure change in mmHg and the x-axis measures time after dosing in hours.*

FDA Label Image

Figure5 (Sildenafil Fig5)

A line graph depicting mean plasma concentrations of Sildenafil over time in healthy male volunteers. The x-axis shows time post dose in hours, ranging from 0 to 24 hours, and the y-axis shows plasma concentrations in ng/mL, up to 500 ng/mL. The curve represents plasma levels after administration of a commercial Sildenafil tablet, showing a peak concentration shortly after dosing followed by a gradual decline over 24 hours.*

FDA Label Image

Figure6 (Sildenafil Fig6)

Two bar graphs illustrating the effect of Sildenafil and placebo on maintenance of erection by baseline score. The x-axis represents baseline scores from 0 to 5 while the y-axis shows the percentage of patients at endpoint. Different shades represent scores 0 to 5, comparing patient distribution between Sildenafil and placebo groups.*

FDA Label Image

Figure7 (Sildenafil Fig7)

A bar chart illustrating the percentage of patients reporting improvement in erections across four treatment groups: placebo, Sildenafil 25 mg, Sildenafil 50 mg, and Sildenafil 100 mg. The chart shows increasing patient-reported improvement with higher Sildenafil doses compared to placebo.*

FDA Label Image

Sildenafil-fig8 (Sildenafil Fig8)

Label for Sildenafil Tablets USP 25 mg by HEC Pharm USA Inc. The white label shows the proprietary name Sildenafil prominently with the strength 25 mg noted below. It states the package contains 30 film-coated oral tablets and is prescription-only. Storage instructions and manufacturer details from Sunshine Lake Pharma Co., Ltd., Guangdong Province, China, are also included along with a barcode and NDC number 72303-0845-1.*

FDA Label Image

Sildenafil-fig9 (Sildenafil Fig9)

Label for Sildenafil Tablets USP 50 mg by HEC Pharm USA Inc. The film-coated oral tablets come in a bottle of 30 tablets. The label includes storage instructions (20° to 25°C preferred) and states Rx only. Manufactured by Sunshine Lake Pharma Co., Ltd., Guangdong Province, China. NDC 72303-0846-1 is displayed alongside a barcode.*

FDA Label Image

Structure (Sildenafil Str)

Chemical structure diagram of Sildenafil, showing its molecular composition and arrangement, including functional groups and rings characteristic to the molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.